ArticleJournal of gynecologic oncology2025

Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential.

Sho Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.